학술논문
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis
Document Type
Article
Author
Mayo, M.J.; Vierling, J.M.; Bowlus, C.L.; Levy, C.; Hirschfield, G.M.; Neff, G.W.; Galambos, M.R.; Gordon, S.C.; Borg, B.B.; Harrison, S.A.; Thuluvath, P.J.; Goel, A.; Shiffman, M.L.; Swain, M.G.; Jones, D.E.J.; Trivedi, P.; Kremer, A.E.; Aspinall, R.J.; Sheridan, D.A.; Dörffel, Y.; Yang, K.; Choi, Y.-J.; McWherter, C.A.
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, January 2024, 59(2):186-200)
Subject
Language
English
ISSN
13652036
02692813
02692813